John Verducci - First Ascent Biomedical

ASCO 2024 Clinical Results

Our study shows the technical feasibility of integrating functional precision [...]

Our studies demonstrate the potential for predictive and generative artificial [...]

John Verducci2024-06-01T02:16:28+00:00June 1, 2024|Press Release|

First Ascent Biomedical Presents Findings from Clinical Studies in Pediatric [...]

John Verducci2024-04-29T15:42:56+00:00April 29, 2024|Publication|

First Ascent Biomedical Inc., a clinical-stage functional precision medicine company [...]

John Verducci2024-04-18T23:42:36+00:00April 18, 2024|Publication|

Inside Precision Medicine April 18, 2024 IPM interviewed Dr. Diana [...]

John Verducci2024-04-23T22:19:23+00:00April 11, 2024|Press Release|

Groundbreaking findings published in Nature Medicine shows improved outcomes [...]

Function Precision Medicine (FPM) and AI to provide new treatment [...]

John Verducci2023-06-15T18:31:47+00:00June 15, 2023|Publication|

Risk or presence of metastasis in medulloblastoma causes substantial treatment-related [...]

John Verducci2023-06-15T19:02:20+00:00March 23, 2023|Publication|

Systemic therapy for metastatic clear cell sarcoma (CCS) bearing EWSR1-CREB1/ATF1 [...]

John Verducci2023-06-15T18:24:42+00:00September 17, 2022|Publication|

Over the past 25 years, chemotherapy regimens for osteosarcoma have [...]